Sun Pharm Company Profile

What is the competitive landscape for SUN PHARM, and what generic alternatives to SUN PHARM drugs are available?

SUN PHARM has five hundred and forty-eight approved drugs.

There are thirty-three US patents protecting SUN PHARM drugs. There are eighteen tentative approvals on SUN PHARM drugs.

There are three hundred and seventy-nine patent family members on SUN PHARM drugs in fifty-eight countries and six hundred and nineteen supplementary protection certificates in nineteen countries.

Summary for Sun Pharm

International Patents:	379
US Patents:	33
Tradenames:	354
Ingredients:	328
NDAs:	548
Patent Litigation for Sun Pharm:	See patent lawsuits for Sun Pharm
PTAB Cases with Sun Pharm as petitioner:	See PTAB cases with Sun Pharm as petitioner

Drugs and US Patents for Sun Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Inc	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	acetaminophen; tramadol hydrochloride	TABLET;ORAL	077184-001	Dec 16, 2005	AB	RX	No	No
Sun Pharm Inds Inc	CARVEDILOL	carvedilol	TABLET;ORAL	077346-001	Sep 5, 2007		DISCN	No	No
Sun Pharm Industries	TOLAZAMIDE	tolazamide	TABLET;ORAL	071357-001	Jul 16, 1987		DISCN	No	No
Sun Pharm Inds Ltd	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075556-002	Aug 22, 2000		DISCN	No	No
Sun Pharm Inds Ltd	OXYMORPHONE HYDROCHLORIDE	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	203506-006	Apr 24, 2015		DISCN	No	No
Sun Pharm Industries	SYNALGOS-DC	aspirin; caffeine; dihydrocodeine bitartrate	CAPSULE;ORAL	011483-004	Sep 6, 1983		DISCN	Yes	No
Sun Pharm	DESVENLAFAXINE	desvenlafaxine fumarate	TABLET, EXTENDED RELEASE;ORAL	205583-001	Jan 28, 2014		DISCN	Yes	No

Expired US Patents for Sun Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-006	Aug 15, 2014	9,089,534
Sun Pharm Industries	BACTRIM	sulfamethoxazole; trimethoprim	SUSPENSION;ORAL	017560-001	Approved Prior to Jan 1, 1982	RE28636
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-002	May 25, 2012	8,367,102
Sun Pharm Industries	BACTRIM DS	sulfamethoxazole; trimethoprim	TABLET;ORAL	017377-002	Approved Prior to Jan 1, 1982	RE28636
Sun Pharm Inds Inc	BACTRIM	sulfamethoxazole; trimethoprim	INJECTABLE;INJECTION	018374-001	Approved Prior to Jan 1, 1982	3,551,564
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-001	May 25, 2012	8,952,064
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-004	May 25, 2012	7,435,427

Paragraph IV (Patent) Challenges for SUN PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	25 mg		2016-05-16
	Tablets	125 mg		2018-07-23
	Capsules	20 mg		2013-01-07
	Capsules	35 mg		2015-11-25
	Delayed-release Tablets	20 mg		2015-06-03
	Capsules	30 mg and 40 mg		2012-12-31
	Capsules	20 mg		2013-06-19

International Patents for Sun Pharm Drugs

Country	Patent Number	Estimated Expiration
Slovenia	2503004
European Patent Office	2021328
Poland	2021328
Israel	194818
Malaysia	153574
Croatia	P20151174
China	106687112

Supplementary Protection Certificates for Sun Pharm Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2139494	2020C/533	Belgium		PRODUCT NAME: QTERN -SAXAGLIPTINE ET DAPAGLIFLOZINE; AUTHORISATION NUMBER AND DATE: EU/1/16/1108 20160719
1084705	PA2014043	Lithuania		PRODUCT NAME: SAXAGLIPTINUM; REGISTRATION NO/DATE: EU/1/09/545/001-015 20091001
0303507	64/1997	Austria		PRODUCT NAME: ''NARATRIPTAN'', GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATES EINSCHLIESSLICH DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: 1-22059 19970731; FIRST REGISTRATION: SE 13382 19970310
1663996	LUC00039	Luxembourg		PRODUCT NAME: CARIPRAZINE, OPTIONALLY IN THE FORM OF A SALT, INCLUDING THE CARIPRAZINE HYDROCHLORIDE; AUTHORISATION NUMBER AND DATE: EU/1/17/1209 20170717
1746976	300885	Netherlands		PRODUCT NAME: IRINOTECANSUCROSOFAATZOUT; REGISTRATION NO/DATE: EU/1/16/1130 20161018
1261586	2012C/016	Belgium		PRODUCT NAME: UNE COMBINAISON DE PRODUITS DE SAXAGLIPTINE ET DE METFORMINE AINSI QUE TOUT SELS PHARMACEUTIQUEMENT ACCEPTABLES, DONT LES SELS DE CHLORHYDRATE DE SAXAGLIPTINE ET DE METFORMINE; AUTHORISATION NUMBER AND DATE: EU/1/11/731/001 20111128
2822954	18C1035	France		PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Sun Pharm
• Sun Pharm Inds
• Sun Pharm Inds (in)
• Sun Pharm Inds Inc
• Sun Pharm Inds Ltd
• Sun Pharm Industries
• Sun Pharma Global